Immetas Therapeutics
Latest round
- Series A
Last raised
- Sep 2020
Total raised
- $11M
Investors
- 1
About Immetas Therapeutics
Immetas Therapeutics, Inc.Immetas Therapeutics, Inc. specializes in the discovery and development of therapeutics targeting the innate immune system.Immetas specializes in innovative therapeutics that target the innate immune system to manage age-related cancers and inflammatory diseases. The company’s core offerings focus on modulating chronic low-grade inflammation, pivotal in the aging process and related diseases.Immetas generates revenue through product sales and strategic partnerships in the healthcare sector. The company engages in direct-to-consumer transactions and B2B agreements with hospitals and clinics using its therapeutics for patient care. Revenue streams come from flagship products priced based on therapeutic applications, ensuring accessibility while maintaining robust revenue.Immetas Therapeutics, Inc. The company aims to expand its presence in both North America and Europe, specifically increasing its market penetration in emerging healthcare markets by 2025.
Who invested in Immetas Therapeutics
1 investor across 1 round
See all investors in Immetas Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 23, 2020
Amount
$11M
Investors
Questions about Immetas Therapeutics
Who invested in Immetas Therapeutics?
Immetas Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Immetas Therapeutics raised?
Immetas Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Immetas Therapeutics last raise money?
Immetas Therapeutics's most recent round on record is a Series A, in Sep 2020.
What does Immetas Therapeutics do?
Immetas Therapeutics is a biotechnology company.
Where is Immetas Therapeutics headquartered?
Immetas Therapeutics is headquartered in US.
Which VCs invest in companies like Immetas Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Immetas Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Immetas Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.